Delivery Order SPE2DB20D7066-SPE2DB25FC2DP
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award SPE2DB20D7059|SPE2DB24FQMP9 is a $5,926.47 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The award has a completion date of September 16, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies, including the DLA, through its extensive federal contract...
This federal contract award, valued at $1,702.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JOLESSA 0.15 MG-0.03 MG tablets, a medical product, with a completion date of September 13, 2024. This is a firm fixed-price delivery order contract, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,539.51, is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of October 27, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $1,372.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The award is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,310.48 firm fixed price delivery order is for the supply of JOLESSA 0.15 MG-0.03 MG tablets. This contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds several large Indefinite Delivery Contracts (IDCs) with the federal government, including a single-award IDC with DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has a ceiling value of $1,213.53 and an ultimate completion date of May 21, 2024. It is a firm fixed-price delivery order contract type. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products...
This is a $1,663.68 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565221558 JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,046.02, is a Firm Fixed Price Delivery Order for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jolessa 0.15 mg-0.03 mg tablets. The $1,109.49 firm fixed-price contract has an ultimate completion date of October 8, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,545.13 firm fixed-price delivery order contract is for the supply of JOLESSA TABS 3X 91S, a pharmaceutical product. The contract has an ultimate completion date of September 26, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a...